Bailard’s Boston Scientific BSX Stock Holding History

Bailard’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.4M	Buy	213,197 +11,041	+5%	+$883K	0.31%	72
2025 Q4	$19.3M	Sell	202,156 -1,291	-0.6%	-$127K	0.43%	51
2025 Q3	$19.9M	Sell	203,447 -2,090	-1%	-$216K	0.43%	52
2025 Q2	$22.1M	Buy	205,537 +275	+0.1%	+$27.8K	0.51%	46
2025 Q1	$20.7M	Buy	205,262 +1,237	+0.6%	+$125K	0.53%	44
2024 Q4	$18.2M	Buy	204,025 +270	+0.1%	+$23.8K	0.47%	51
2024 Q3	$17.1M	Buy	203,755 +32,637	+19%	+$2.57M	0.44%	55
2024 Q2	$13.2M	Buy	171,118 +16,053	+10%	+$1.18M	0.36%	60
2024 Q1	$10.6M	Buy	155,065 +31,441	+25%	+$2.02M	0.29%	81
2023 Q4	$7.15M	Buy	+123,624	New	+$6.6M	0.21%	107

Other funds holding BSX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return